Federal Register / Vol. 70, No.

33 / Friday, February 18, 2005 / Notices 8391

Harlowton, Colorado 351. Jennifer and Gary Stone on behalf 365. Kelly and Josef Blake on behalf of
Court of Federal Claims Number 04– of Amelia Stone Allisha Ray Blake
1005V Oshkosh, Wisconsin Charleston, West Virginia
338. Rosemary and Jimmy Ayala on Court of Federal Claims Number 04– Court of Federal Claims Number 04–
behalf of Jimmy Ayala, Jr. 1041V 1084V
Philadelphia, Pennsylvania 352. Michele Siciliano on behalf of 366. Tina Cockrell on behalf of Mark
Court of Federal Claims Number 04– August Siciliano Andrew Carwell
1007V Ligonier, Pennsylvania Mount Vernon, Ohio
339. Francine Jiminez and Albert Court of Federal Claims Number 04– Court of Federal Claims Number 04–
Williams on behalf of Alsay Leday 1054V 1085V
Williams 353. Ingrid Bianco on behalf of Greta Dated: February 11, 2005.
Anaheim, California Bianco Elizabeth M. Duke,
Court of Federal Claims Number 04– Somers Point, New Jersey Administrator.
1008V Court of Federal Claims Number 04–
[FR Doc. 05–3176 Filed 2–17–05; 8:45 am]
340. Quiana Ferguson on behalf of 1059V
BILLING CODE 4165–15–P
Christopher Eugene Ferguson 354. Lonnie Vestal on behalf of Dakota
Dayton, Ohio Vestal
Court of Federal Claims Number 04– Tyler, Texas
DEPARTMENT OF HEALTH AND
1009V Court of Federal Claims Number 04–
HUMAN SERVICES
341. Sonya Tolentino on behalf of 1063V
Nanea Tolentino, Deceased 355. Amy Schlosser on behalf of Daniel National Institutes of Health
Kealakekua, Hawaii Joseph Schlosser
Court of Federal Claims Number 04– Tyler, Texas National Cancer Institute; Notice of
1014V Court of Federal Claims Number 04– Closed Meeting
342. Kimberly Dixon on behalf of Karl 1064V
Coleman 356. Cheryl Thompson on behalf of Pursuant to section 10(d) of the
New Orleans, Louisiana Aaron Thompson Federal Advisory Committee Act, as
Court of Federal Claims Number 04– Tyler, Texas amended (5 U.S.C. Appendix 2), notice
1022V Court of Federal Claims Number 04– is hereby given of the following
343. Terri and Oscar Finley on behalf of 1065V meeting.
Donovan Finley 357. Theresa and Dale Conkel on behalf The meeting will be closed to the
New Orleans, Louisiana of Mark Conkel public in accordance with the
Court of Federal Claims Number 04– Richardson, Texas provisions set forth in sections
1023V Court of Federal Claims Number 04– 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
344. Jacqueline and Steven Gilbert on 1072V as amended. The contract proposals and
behalf of Taylor Gilbert 358. Sonia and Hector Rosado on behalf the discussions could disclose
New Orleans, Louisiana of Hector Rosado confidential trade secrets or commercial
Court of Federal Claims Number 04– Miami, Florida property such as patentable material,
1024V Court of Federal Claims Number 04– and personal information concerning
345. Sabrina and Clarence Toussaint on 1076V individuals associated with the contract
behalf of Allen Toussaint 359. Heather Hamilton on behalf of proposals, the disclosure of which
New Orleans, Louisiana Logan Hamilton, Deceased would constitute a clearly unwarranted
Court of Federal Claims Number 04– Edmund, Oklahoma invasion of personal privacy.
1025V Court of Federal Claims Number 04– Name of Committee: National Cancer
346. Lauren and David Mason on behalf 1077V Institute Special Emphasis Panel,
of Sage Mason 360. Lori Quast on behalf of Steven Metabolomics for Early Cancer Detection.
Limestone, Texas Quast Date: March 22, 2005.
Court of Federal Claims Number 04– Mattoon, Illinois Time: 1 p.m. to 4 p.m.
1027V Court of Federal Claims Number 04– Agenda: To review and evaluate contract
347. Kathleen and Neil Doherty on 1078V proposals.
Place: National Institutes of Health, 6116
behalf of Connor Doherty 361. Teresa and Steven Myers on behalf
Executive Boulevard, Rockville, MD 20852,
Woodburn, Massachusetts of Audrey Myers (Telephone Conference Call).
Court of Federal Claims Number 04– Charlotte, North Carolina Contact Person: Thomas M. Vollberg, PhD,
1033V Court of Federal Claims Number 04– Scientific Review Administrator, Special
348. Brenda and Ronald Knable on 1079V Review and Logistics Branch, Division of
behalf of Paul Knable 362. Katie Jaynes on behalf of Marcus Extramural Activities, National Cancer
Chicago, Illinois Cetell Institute, 6116 Executive Blvd., Room 7142,
Court of Federal Claims Number 04– Somers Point, New Jersey Bethesda, MD 20892, (301) 594–9582,
1034V Court of Federal Claims Number 04– volbert@mail.nih.gov.
349. Thomas Bell on behalf of Annmarie 1080V Any interested person may file written
363. Bruce Stearns comments with the committee by forwarding
Bell
the statement to the Contract Person listed on
Suffolk, Virginia Saint Croix Falls, Wisconsin this notice. The statement should include the
Court of Federal Claims Number 04– Court of Federal Claims Number 04– name, address, telephone number and when
1038V 1082V applicable, the business or professional
350. Carla and Kevin Long on behalf of 364. Cathleen and John Akers on behalf affiliation of the interested person.
Colin James Long of John Henry Akers (Catalogue of Federal Domestic Assistance
Vancouver, Washington Houston, Texas Program Nos. 93.392, Cancer Construction;
Court of Federal Claims Number 04– Court of Federal Claims Number 04– 93.393, Cancer Cause and Prevention
1039V 1083V Research; 93.394, Cancer Detection and

VerDate jul<14>2003 15:41 Feb 17, 2005 Jkt 205001 PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 E:\FR\FM\18FEN1.SGM 18FEN1
 8392 Federal Register / Vol. 70, No. 33 / Friday, February 18, 2005 / Notices
Diagnosis Research, 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 10, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–3156 Filed 2–17–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary
and Alternative Medicine; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel Training and
Education.
Date: March 7–8, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Laurie Friedman Donze,
PhD, Scientific Review Administrator,
National Center for Complement. & Alt.
Medicine, National Institutes of Health, 6707
Democracy Blvd. Suite 401, Bethesda, MD
20892, (301) 402–1030,
donzel2@mail.nih.gov.
Dated: February 10, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–3169 Filed 2–17–05; 8:45 am]
BILLING CODE 4140–01–M
VerDate jul<14>2003 15:41 Feb 17, 2005 Jkt 205001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel Comprehensive International
Program of Research on AIDS (CIPRA).
Date: March 8–9, 2005.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Eugene R. Baizman, PhD,
Scientific Review Administrator, Scientific
Review Program, Division of Extramural
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7616,
Bethesda, MD 20892, (301) 402–1464.
eb237e@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel Food Allergy Research
Consortium and Statistical Center.
Date: March 14, 2005.
Time: 11:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Bethesda, MD 20817. (Telephone conference
call.)
Contact Person: Gregory P. Jarosik, PhD,
Scientific Review Administrator, Scientific
Review Program, Division of Extramural
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7616,
Bethesda, MD 20892, 301-496–0695.
gjarosik@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS.)
PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\18FEN1.SGM
Dated: February 11, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–3153 Filed 2–17–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel, ZAA1 HH (31) PAR–03–133
Rapid Response to College Drinking
Problems—U18 Applications.
Date: March 4, 2005.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Select Bethesda, 8120
Wisconsin Ave., Bethesda, MD 20814.
Contact Person: Jeffrey I. Toward, PhD,
Scientific Review Administrator, National
Institutes of Health, National Institute on
Alcohol Abuse and Alcoholism, Extramural
Project Review Branch, OEA, 5635 Fishers
Lane, Room 3033, Bethesda, MD 20892–9304.
(301) 435–5337. jtoward@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants,
National Institutes of Health, HHS.)
Dated: February 11, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–3154 Filed 2–17–05; 8:45 am]
BILLING CODE 4140–01–M
18FEN1